Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

7Total

Not Applicable (6)

P 2 (1)

Trial Status

Completed5

Recruiting3

Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07209683Not ApplicableRecruiting

The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults

NCT07392723Phase 2Recruiting

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

NCT07379437Not ApplicableNot Yet RecruitingPrimary

Haematococcus Pluvialis Astaxanthin for Brain Aging

NCT05024916Not ApplicableCompletedPrimary

Blueberry Intervention Study for Brain Aging

NCT01686516CompletedPrimary

Synaptic Plasticity Imaging with Diffusion MRI

NCT06137339Not ApplicableRecruitingPrimary

AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults

NCT02957422Not ApplicableCompletedPrimary

Milk Intervention Study for Brain Aging

NCT02702570Not ApplicableCompletedPrimary

Committed Actions for Successful Aging

NCT01273311CompletedPrimary

CARDIA Brain MRI Substudy

Showing all 9 trials

Brain Aging